Related Experiment Video
Updated: Jan 11, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Left Ventricular Diastolic Dysfunction Increases the Risk of Medium-term Mortality in Patients with Cirrhotic Ascites
Sheng-Hao Li1, Lu Zhang1, Hong-Juan Li2
1School of Public Health, School of Public Health, Dali University, no. 2, Hongsheng Road, Dali Town, Dali Bai Autonomous Prefecture, Dali City 671000, Yunnan Province, P.R. China.
Insights
Left ventricular diastolic dysfunction (LVDD) is an independent risk factor for 1-year mortality in patients with cirrhotic ascites. Early detection of LVDD can help predict prognosis, especially in patients without hepatic malignancy.
Area of Science:
- Cardiology
- Hepatology
- Medical Prognostics
Background:
- Cirrhotic ascites is a common complication of advanced liver disease.
- Left ventricular diastolic dysfunction (LVDD) is increasingly recognized in patients with liver cirrhosis.
- The prognostic implications of LVDD in cirrhotic ascites patients require further elucidation.
Purpose of the Study:
- To investigate the association between left ventricular diastolic dysfunction (LVDD) and medium-term mortality in patients with cirrhotic ascites.
- To identify LVDD as an independent risk factor for 1-year mortality in this population.
- To compare the predictive value of LVDD with established prognostic scores.
Main Methods:
- Retrospective study including 194 patients with cirrhotic ascites.
- Echocardiography used to categorize patients into LVDD and non-LVDD groups.
- Lasso, univariate, and multivariate Cox regression analyses for risk factor identification.
- Kaplan-Meier curves and time-dependent ROC curves for survival analysis.
Main Results:
- Left ventricular diastolic dysfunction (LVDD) was identified in 47.4% of patients.
- LVDD was an independent predictor of 1-year mortality (Hazard Ratio = 2.109, P = 0.003).
- LVDD demonstrated comparable predictive performance to CTP and MELD scores for 1-year mortality, particularly in patients without hepatic malignancy.
Conclusions:
- Left ventricular diastolic dysfunction (LVDD) significantly increases the risk of 1-year mortality in patients with cirrhotic ascites.
- LVDD serves as a valuable prognostic marker, especially in cirrhotic ascites patients without hepatic malignancy.
- Routine echocardiographic assessment for LVDD may aid in risk stratification and management of cirrhotic ascites.
Objective:
To elucidate the impact of left ventricular diastolic dysfunction (LVDD) on the risk of medium-term poor prognosis in patients with cirrhotic ascites.
Methods:
A total of 194 patients with cirrhotic ascites were included in this retrospective study and categorized into two groups (LVDD and non-LVDD) based on echocardiography findings. Lasso and univariate Cox regression analyses were initially used to screen potential influencing factors of 1-year mortality from basic clinical data. Multivariate Cox regression was then performed to identify independent risk factors. Kaplan-Meier (K-M) and time-dependent receiver operating characteristic (ROC) curves were used to assess the predictive value of LVDD for 1-year mortality. Subgroup analysis was also conducted based on the presence or absence of hepatic malignancy.
Results:
(1)LVDD was present in 47.4% (92/194) of patients with cirrhotic ascites; (2)Regression analyses (Lasso, univariate Cox, and multivariate Cox) revealed that LVDD (hazard ratio = 2.109, 95% confidence interval [1.279-3.478], P = 0.003) was an independent risk factor for 1-year mortality; (3)Time-dependent ROC curves demonstrated that the predictive performance of LVDD for 360-day mortality, in the overall population and patients without hepatic malignancy, was comparable to that of traditional Child-Turcotte-Pugh (CTP) and Model for End-Stage Liver Disease (MELD) scores (P > 0.05 for all).
Conclusion:
LVDD increases the risk of 1-year mortality in patients with cirrhotic ascites, particularly in those without hepatic malignancy.
More Related Videos
Related Concept Videos
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

